EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM

Syeda Sumayya Tariq, Muhammad Salman Haleem, Reaz Uddin iD

RSC Advances · 2026 · 16 (31) · 28845-28856

DOI: 10.1039/d6ra02379g ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Syeda Sumayya Tariq und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi Karach…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using generative chemical language modeling (CLM) for the design and discovery of novel KPC-2 Inhibitors targeting Klebsiella pneumonia .

Autor:innen und Institutionen

  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi Karachi-75270 Pakistan mriazuddin@iccs.edu.
  • School of Electronic Engineering and Computer Science, Queen Mary University of London E1 4NS UK.
  • Western Caspian University Baku Azerbaijan.

ORCID-Profile: Reaz Uddin

Zitieren

APA

Tariq, S. S., Haleem, M. S., & Uddin, R. (2026). Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM. RSC Advances, 16(31), 28845-28856. https://doi.org/10.1039/d6ra02379g

Vancouver

Tariq SS, Haleem MS, Uddin R. Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM. RSC Advances. 2026;16(31):28845-28856. doi:10.1039/d6ra02379g

BibTeX
@article{Tariq2026,
  author = {Tariq, Syeda Sumayya and Haleem, Muhammad Salman and Uddin, Reaz},
  title = {Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {31},
  pages = {28845--28856},
  doi = {10.1039/d6ra02379g}
}
Kostenlos starten →